Thomson Reuters today announced that it has donated two ScholarOne Manuscripts sites to the newest members of the African Journal Partnership Project -- the Medical Journal of Zambia, John S. Kachimba, Editor; and the Ethiopian Journal of Health Services, Abraham Haileamlak, Editor. Since 2005, Thomson Reuters has worked with the Council of Science Editors to assist editors of sub-Saharan medical journals increase the visibility and quality of their journals. These journals and their editors include the Ghana Medical Journal, Dr. David Ofori-Adjei, Editor; the Malawi Medical Journal, Dr. Chiwoza Bandawe, Editor; Mali Medical, Dr. Siaka Sidibe, Editor; and African Health Sciences, Dr. James Tumwine, Editor-in-Chief.
ScholarOne Manuscripts is an innovative, web-based peer review and submission application for scholarly publishers. With ScholarOne Manuscripts, these journals automate the manuscript submission process, allowing for easy administrative, editing and reviewing capabilities.
"These are journals that may not otherwise have had the resources to acquire the electronic tools necessary to elevate their journals to the next level," said Keith Collier, vice president and general manager of ScholarOne, Thomson Reuters. "We are excited to see this project continue to grow and strengthen its commitment to support medical research in Africa."
"The donation of ScholarOne Manuscripts to the Medical Journal of Zambia and the Ethiopian Journal of Health Sciences will further their ability to reach the primary goals of the African Journal Partnership Project -- to help improve the editorial quality of these African journals and thereby help raise the visibility of African science," said Dr. Christine Laine, President of the Council of Science Editors, and Editor of Annals of Internal Medicine, one of the northern partner journals. The other partner journals include the BMJ, Environmental Health Perspectives, The Lancet, JAMA, and New England Journal of Medicine.
The African Journal Partnership Project is funded by the National Library of Medicine and the Fogarty International Center of the US National Institutes for Health and administered by the Council of Science Editors.
Tirzepatide significantly reduces weight and diabetes risk in patients with obesity and prediabetes